<DOC>
	<DOCNO>NCT00332124</DOCNO>
	<brief_summary>This study evaluate safety effectiveness take choline supplement pregnancy , whether choline supplementation effect infant development .</brief_summary>
	<brief_title>Safety Effectiveness Taking Choline Supplements During Pregnancy Improving Infant Brain Development</brief_title>
	<detailed_description>Choline essential nutrient find food , egg yolk , liver , meat . It important composition repair normal cellular membrane , normal brain function , normal cardiovascular function . Research suggest presence adequate amount choline pregnancy breastfeed help ensure healthy fetal brain development . Additionally , adequate prenatal choline level may long-lasting positive effect cognitive function , include memory . However , sufficient research do effect choline pregnant woman unborn baby . This study evaluate safety effectiveness take choline supplement pregnancy , whether take choline pregnancy effect infant development . Participants double-blind study randomly assign receive either placebo 900 mg choline daily throughout pregnancy , delivery . Babies begin receive either placebo choline daily time birth 3 month old . Participants attend baseline study visit include eligibility assessment , urine collection , measurement vital sign , dispense study medication , ultrasound . Subsequent study visit occur every 4 week throughout pregnancy 6 month postpartum . Vital sign take , urine sample collect , study medication give visit . Two blood sample take Weeks 32 36 gestation . Heel stick perform baby 4 12 week old . Follow-up visit hold every 6 month baby 18 month old .</detailed_description>
	<mesh_term>Choline</mesh_term>
	<criteria>Pregnant Between 10 18 week gestational age Healthy Diagnosis psychosis Use tobacco nicotine product Drinks 1 alcoholic drink per day Use illicit drug History trimethylaminuria History kidney disease History liver disease History prepregnancy diabetes History Parkinson 's disease History fetal death , fetal/infant congenital malformation , fetal/infant genetic abnormality Evidence noncompliance study medication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>